Literature DB >> 18351461

Overexpression of Cdk5 or non-phosphorylatable retinoblastoma protein protects septal neurons from oxygen-glucose deprivation.

Kiran S Panickar1, Doris Nonner, Michael G White, John N Barrett.   

Abstract

Activation of cyclin dependent kinases (Cdks) contributes to neuronal death following ischemia. We used oxygen-glucose deprivation (OGD) in septal neuronal cultures to test for possible roles of cell cycle proteins in neuronal survival. Increased cdc2-immunoreactive neurons were observed at 24 h after the end of 5 h OGD. Green fluorescent protein (GFP) or GFP along with a wild type or dominant negative form of the retinoblastoma protein (Rb), or cyclin-dependent kinase5 (Cdk5), were overexpressed using plasmid constructs. Following OGD, when compared to controls, neurons expressing both GFP and dominant negative Rb, RbDeltaK11, showed significantly less damage using microscopy imaging. Overexpression of Rb-wt did not affect survival. Surprisingly, overexpression of Cdk5-wild type significantly protected neurons from process disintegration but Cdk5T33, a dominant negative Cdk5, gave little or no protection. Thus phosphorylation of the cell cycle regulator, Rb, contributes to death in OGD in septal neurons but Cdk5 can have a protective role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351461     DOI: 10.1007/s11064-008-9647-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  53 in total

Review 1.  Functions of the retinoblastoma protein.

Authors:  W G Kaelin
Journal:  Bioessays       Date:  1999-11       Impact factor: 4.345

2.  Bone morphogenetic proteins (BMP6 and BMP7) enhance the protective effect of neurotrophins on cultured septal cholinergic neurons during hypoglycemia.

Authors:  D Nonner; E F Barrett; P Kaplan; J N Barrett
Journal:  J Neurochem       Date:  2001-04       Impact factor: 5.372

3.  Phosphorylation of retinoblastoma protein in rat brain after transient middle cerebral artery occlusion.

Authors:  T Hayashi; K Sakai; C Sasaki; W R Zhang; K Abe
Journal:  Neuropathol Appl Neurobiol       Date:  2000-08       Impact factor: 8.090

Review 4.  Cyclin-dependent kinases as potential targets to improve stroke outcome.

Authors:  Michael O'Hare; Fuhu Wang; David S Park
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

5.  Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.

Authors:  M Zheng; C L Leung; R K Liem
Journal:  J Neurobiol       Date:  1998-05

6.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

7.  Serum factor supporting long-term survival of rat central neurons in culture.

Authors:  L M Kaufman; J N Barrett
Journal:  Science       Date:  1983-06-24       Impact factor: 47.728

Review 8.  Cdk5 behind the wheel: a role in trafficking and transport?

Authors:  Deanna S Smith; Li Huei Tsai
Journal:  Trends Cell Biol       Date:  2002-01       Impact factor: 20.808

9.  Decreased brain infarct following focal ischemia in mice lacking the transcription factor E2F1.

Authors:  J P MacManus; C J Koch; M Jian; T Walker; B Zurakowski
Journal:  Neuroreport       Date:  1999-09-09       Impact factor: 1.837

10.  Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival.

Authors:  Bing-Sheng Li; Wu Ma; Howard Jaffe; Yali Zheng; Satoru Takahashi; Lei Zhang; Ashok B Kulkarni; Harish C Pant
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

View more
  4 in total

1.  Phospho-Rb mediating cell cycle reentry induces early apoptosis following oxygen-glucose deprivation in rat cortical neurons.

Authors:  Ying Yu; Qing-Guo Ren; Zhao-Hui Zhang; Ke Zhou; Zhi-Yuan Yu; Xiang Luo; Wei Wang
Journal:  Neurochem Res       Date:  2011-10-30       Impact factor: 3.996

2.  Activation of ataxia telangiectasia muted under experimental models and human Parkinson's disease.

Authors:  Antoni Camins; Javier G Pizarro; Daniel Alvira; Javier Gutierrez-Cuesta; Aurelio Vazquez de la Torre; Jaume Folch; Francesc X Sureda; Ester Verdaguer; Felix Junyent; Joaquín Jordán; Isidre Ferrer; Mercè Pallàs
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

3.  Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage.

Authors:  Seung-Hoon Baek; Ah Reum Noh; Kyeong-A Kim; Muhammad Akram; Young-Jun Shin; Eun-Sun Kim; Seong Woon Yu; Arshad Majid; Ok-Nam Bae
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

4.  The role of Cdk5 in neuroendocrine thyroid cancer.

Authors:  Karine Pozo; Emely Castro-Rivera; Chunfeng Tan; Florian Plattner; Gert Schwach; Veronika Siegl; Douglas Meyer; Ailan Guo; Justin Gundara; Gabriel Mettlach; Edmond Richer; Jonathan A Guevara; Li Ning; Anjali Gupta; Guiyang Hao; Li-Huei Tsai; Xiankai Sun; Pietro Antich; Stanley Sidhu; Bruce G Robinson; Herbert Chen; Fiemu E Nwariaku; Roswitha Pfragner; James A Richardson; James A Bibb
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.